Pharmaceutical and Healthcare latest pipeline guide Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2020 - PowerPoint PPT Presentation

About This Presentation
Title:

Pharmaceutical and Healthcare latest pipeline guide Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2020

Description:

The Amyotrophic Lateral Sclerosis (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Amyotrophic Lateral Sclerosis and features dormant and discontinued projects. For information visit - – PowerPoint PPT presentation

Number of Views:29

less

Transcript and Presenter's Notes

Title: Pharmaceutical and Healthcare latest pipeline guide Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2020


1
Amyotrophic Lateral Sclerosis - Pipeline Review,
H2 2020
  • Pharmaceuticals and Healthcare

Published Date Nov 2020
No. of Pages 868
Country Global
Category Pharmaceuticals and Healthcare
Single User License USD 2500
Web www.aarkstore.com Phone -  91 9987295242
Mail Us contact_at_aarkstore.com
2
Summary
  • Latest Pharmaceutical and Healthcare disease
    pipeline guide Amyotrophic Lateral Sclerosis -
    Pipeline Review, H2 2020, provides an overview of
    the Amyotrophic Lateral Sclerosis (Central
    Nervous System) pipeline landscape.

Web www.aarkstore.com Phone -  91 9987295242
Mail Us contact_at_aarkstore.com
3
Summary
  • Amyotrophic lateral sclerosis (als) is the most
    common degenerative disease of the motor neuron
    system. The disorder is named for its underlying
    pathophysiology, with amyotrophy referring to the
    atrophy of muscle fibers, which are denervated as
    their corresponding anterior horn cells
    degenerate. Lateral sclerosis refers to the
    changes seen in the lateral columns of the spinal
    cord as upper motor neuron (umn) axons in these
    areas degenerate and are replaced by fibrous
    astrocytes (gliosis). Symptoms include difficulty
    breathing, difficulty swallowing, head drop due
    to weakness of the neck muscles, muscle cramps,
    speech problems, such as A slow or abnormal
    speech pattern (slurring of words), voice
    changes, hoarseness, weight loss.

Web www.aarkstore.com Phone -  91 9987295242
Mail Us contact_at_aarkstore.com
4
Report Highlights
  • Pharmaceutical and healthcare latest
    pipeline guide amyotrophic lateral sclerosis -
    pipeline review, H2 2020, provides comprehensive
    information on the therapeutics under development
    for amyotrophic lateral sclerosis (central
    nervous system), complete with analysis by stage
    of development, drug target, mechanism of action
    (moa), route of administration (roa) and molecule
    type. The guide covers the descriptive
    pharmacological action of the therapeutics, its
    complete research and development history and
    latest news and press releases.The amyotrophic
    lateral sclerosis (central nervous system)
    pipeline guide also reviews of key players
    involved in therapeutic development for
    amyotrophic lateral sclerosis and features
    dormant and discontinued projects. The guide
    covers therapeutics under development by
    companies /universities /institutes, the
    molecules developed by companies in
    pre-registration, filing rejected/withdrawn,
    phase III, phase II, phase I, IND/CTA filed,
    preclinical, discovery and unknown stages are 2,
    2, 13, 30, 26, 6, 125, 44 and 3 respectively.
    Similarly, the universities portfolio in phase
    II, phase I, preclinical and discovery stages
    comprises 1, 1, 36 and 13 molecules,
    respectively.Amyotrophic lateral sclerosis
    (central nervous system) pipeline guide helps in
    identifying and tracking emerging players in the
    market and their portfolios, enhances decision
    making capabilities and helps to create effective
    counter strategies to gain competitive advantage.
    The guide is built using data and information
    sourced from global markets directs proprietary
    databases, company/university websites, clinical
    trial registries, conferences, SEC filings,
    investor presentations and featured press
    releases from company/university sites and
    industry-specific third party sources.
    Additionally, various dynamic tracking processes
    ensure that the most recent developments are
    captured on a real time basis.Note certain
    content / sections in the pipeline guide may be
    removed or altered based on the availability and
    relevance of data.

Web www.aarkstore.com Phone -  91 9987295242
Mail Us contact_at_aarkstore.com
5
Scope
  • - The pipeline guide provides a snapshot of the
    global therapeutic landscape of amyotrophic
    lateral sclerosis (central nervous system).- The
    pipeline guide reviews pipeline therapeutics for
    amyotrophic lateral sclerosis (central nervous
    system) by companies and universities/research
    institutes based on information derived from
    company and industry-specific sources.- The
    pipeline guide covers pipeline products based on
    several stages of development ranging from
    pre-registration till discovery and undisclosed
    stages.- The pipeline guide features descriptive
    drug profiles for the pipeline products which
    comprise, product description, descriptive
    licensing and collaboration details, RD brief,
    moa other developmental activities.- The
    pipeline guide reviews key companies involved in
    amyotrophic lateral sclerosis (central nervous
    system) therapeutics and enlists all their major
    and minor projects.- The pipeline guide
    evaluates amyotrophic lateral sclerosis (central
    nervous system) therapeutics based on mechanism
    of action (moa), drug target, route of
    administration (roa) and molecule type.- The
    pipeline guide encapsulates all the dormant and
    discontinued pipeline projects.- The pipeline
    guide reviews latest news related to pipeline
    therapeutics for amyotrophic lateral sclerosis
    (central nervous system)

Web www.aarkstore.com Phone -  91 9987295242
Mail Us contact_at_aarkstore.com
6
Reasons to Buy
  • - Procure strategically important competitor
    information, analysis, and insights to formulate
    effective RD strategies.- Recognize emerging
    players with potentially strong product portfolio
    and create effective counter-strategies to gain
    competitive advantage.- Find and recognize
    significant and varied types of therapeutics
    under development for amyotrophic lateral
    sclerosis (central nervous system).- Classify
    potential new clients or partners in the target
    demographic.- Develop tactical initiatives by
    understanding the focus areas of leading
    companies.- Plan mergers and acquisitions
    meritoriously by identifying key players and its
    most promising pipeline therapeutics.- Formulate
    corrective measures for pipeline projects by
    understanding amyotrophic lateral sclerosis
    (central nervous system) pipeline depth and focus
    of indication therapeutics.- Develop and design
    in-licensing and out-licensing strategies by
    identifying prospective partners with the most
    attractive projects to enhance and expand
    business potential and scope.- Adjust the
    therapeutic portfolio by recognizing discontinued
    projects and understand from the know-how what
    drove them from pipeline.

Web www.aarkstore.com Phone -  91 9987295242
Mail Us contact_at_aarkstore.com
7
Table of Contents
  • Introduction
  • Amyotrophic Lateral Sclerosis Overview
  • Amyotrophic Lateral Sclerosis - Therapeutics
    Development
  • Amyotrophic Lateral Sclerosis - Therapeutics
    Assessment
  • Amyotrophic Lateral Sclerosis - Companies
    Involved in Therapeutics Development
  • Amyotrophic Lateral Sclerosis - Drug Profiles
  • Amyotrophic Lateral Sclerosis - Dormant Projects
  • Amyotrophic Lateral Sclerosis - Discontinued
    Products
  • Amyotrophic Lateral Sclerosis - Product
    Development Milestones
  • Appendix

Web www.aarkstore.com Phone -  91 9987295242
Mail Us contact_at_aarkstore.com
8
BROWSE FULL MARKET REPORT
  • Amyotrophic Lateral Sclerosis - Pipeline Review,
    H2 2020
  • Related Market Research Reports
  • Healthcare Market Research Reports
  • Pharmaceuticals And Healthcare Market Research
    Reports

Web www.aarkstore.com Phone -  91 9987295242
Mail Us contact_at_aarkstore.com
9
MORE RELATED REPORTS
  • Amyotrophic Lateral Sclerosis Global Clinical
    Trials Review, H1, 2020
  • Global Amyotrophic Lateral Sclerosis Treatment
    Market Research Report 2020-2024
  • North America Amyotrophic Lateral Sclerosis (ALS)
    Treatment Market Report (2014-2024) - Market
    Size, Share, Price, Trend and Forecast
  • Global Amyotrophic Lateral Sclerosis (ALS)
    Treatment Market Report 2019 - Market Size,
    Share, Price, Trend and Forecast
  • Amyotrophic lateral sclerosis (ALS) - Market
    Insight, Epidemiology and Market Forecast - 2028

Web www.aarkstore.com Phone -  91 9987295242
Mail Us contact_at_aarkstore.com
10
ABOUT AARKSTORE
  • Aarkstore Enterprise provides businesses, start-
    ups, market research seekers and enthusiasts with
    all-inclusive yet exclusive market information
    encompassing a number of industry verticals. As
    a leading online market research report seller,
    Aarkstore acts as a platform for accessing
    statistics, forecasts, business insights, ideas,
    concepts and much more

Web www.aarkstore.com Phone -  91 9987295242
Mail Us contact_at_aarkstore.com
11
Web www.aarkstore.com Phone -  91
9987295242 Mail Us contact_at_aarkstore.com
Write a Comment
User Comments (0)
About PowerShow.com